Testing of 2 NEJM journals: Catalyst and Evidence from October 3 to December 1, 2022
We offer 2 journals from the publisher NEJM for testing from October 3 to December 1, 2022:
NEJM Catalyst brings health care executives, clinical leaders, and clinicians together to share innovative ideas and practical applications for enhancing the value of health care delivery. From a network of top thought leaders, experts, and advisors, our digital, peer-reviewed journal, live-streamed events, and qualified Insights Council provide real-life examples and actionable solutions to help organizations address urgent challenges affecting health care.
NEJM Evidence, a new monthly digital journal from NEJM Group, presents innovative original research and fresh, bold ideas in clinical trial design and clinical decision-making.
